Impaired Heart Microvessel Function Linked to Doubled Risk of Death and Heart Attack
While the heart pumps blood throughout the body, the cardiac muscle itself relies on a continuous supply delivered not only by large coronary...
Search results for "Europe"
Sudden Cold Sweats and Blurred Vision: Why You Should Lie Down, Not Tough It Out
A sudden wave of nausea hits, cold sweat breaks out, vision blurs, ears feel plugged, and a profound weakness sweeps through the entire body.
Building Muscle vs. Living Longer: Why Plant Protein Is the Smarter Choice for Sarcopenia
Inadequate protein intake remains a genuine concern for older adults facing sarcopenia—the age-related loss of muscle...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker.
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
Biopharmaceutical company Celltrion announced on Aug. 27 that combined first-half sales of its subcutaneous infliximab...
Single Abdominal Ultrasound Can Gauge Liver Cancer Risk in Fatty Liver Patients, Study Finds
Fatty liver disease is one of the most common findings during routine health screenings.
Bizarre Preseason Accident: Juventus Defender Federico Gatti Hurt in Pitch Invasion
A bizarre injury unfolded in Italian football as national-team defender Federico Gatti, 28, was sidelined after an...
Same Arthritis Drug, Different Results: Why Treatment Nonresponse Is Not Your Fault
If two patients take the exact same medication, why does one recover while the other sees little to no improvement.
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...